Vernal Biosciences, Inc. — Form D/A
Vernal Biosciences, Inc. of Colchester, VT, a company, filed a Form D amendment with the SEC on 2023-06-16. The offering totals $41.0M, of which $41.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-06-16
- Form: D/A
- Accession: 0001861147-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41.0M
- Amount sold: $41.0M
- Investors: 10
- Date of first sale: 2022-05-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446902
Issuer
- Name: Vernal Biosciences, Inc.
- CIK: 0001861147
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 261 Mountain View Drive, Colchester, VT, 05461
- Phone: 512-791-9680
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Anderson | Director | Calgary, A0 |
| Christian Cobaugh | Director | Colchester, VT |
| Daniella Kranjac | Director | New York, NY |
| Christian Cobaugh | Executive Officer | Colchester, VT |
| Errik Anderson | Director | Cambridge, MA |
| Gustavo Mahler | Director | Colchester, VT |
Other filings by this issuer (2)
More